Page last updated: 2024-10-15

dinactin

Description

dinactin: homolog of the above minor; a macrotetrolide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID156588868
MeSH IDM0066566

Synonyms (4)

Synonym
NSC63925 ,
20261-85-2
dinactin
HY-121333

Dosage Studied

ExcerptReference
" Dinactin inhibited T-cell proliferation induced by IL-2, by mAb to CD3, and by mAbs to CD3 plus alpha-CD28 with identical dose-response curves (IC50 = 10-20 ng/ml)."( Effects of cyclosporin A and dinactin on T-cell proliferation, interleukin-5 production, and murine pulmonary inflammation.
Egan, RW; Falcone, A; Garlisi, CG; Hegde, V; Jakway, JP; Kung, TT; Motasim Billah, M; Patel, M; Razac, S; Shah, H; Shortall, J; Stelts, D; Umland, SP, 1999
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (26.67)18.7374
1990's4 (26.67)18.2507
2000's2 (13.33)29.6817
2010's4 (26.67)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]